# Oxaliplatin

NDC: 68083-170
Generic name: Oxaliplatin
Labeler / Manufacturer: Gland Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20170529

FDA application: ANDA207385

## Active ingredients

- OXALIPLATIN: 50 mg/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68083-170"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68083-170
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d6178bc6-9dae-413f-8f47-de75d576c5b8